Scientists are testing a simple blood draw that may spot cancer cells rebuilding long before any scanner picks them up.

Northwestern Medicine scientists and collaborators have demonstrated a novel liquid biopsy technique that can measure cancer burden and reveal molecular characteristics of small cell lung cancer (SCLC ...

A new blood test could detect lung cancer recurrence months before it appears on scans, potentially enabling earlier ...

New findings suggest that a blood test can detect circulating tumor DNA (ctDNA), potentially identifying signs of lung cancer ...

SAN ANTONIO, October 29, 2026--bioAffinity Technologies will share benefits of CyPath Lung with North Carolina lung cancer ...

Freenome revealed SimpleScreen Lung and a pioneering combined test enabling eligible patients to undergo screening for both ...

Key TakeawaysFreenome shares rose 11% today after it launched SimpleScreen Lung, a lung cancer blood test that can run with its FDA-approved colon cancer test from one blood draw. About half of people ...

Please provide your email address to receive an email when new articles are posted on . The proportion of patients who received any lung cancer screening was significantly greater in clinics with vs.

There is a particular kind of fear that settles in after a lung cancer diagnosis — not just fear of the disease, but fear of the waiting. There is a particular kind of fear that settles in after a ...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced that unit ...